(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)methanone

CAS: 3562-84-3

Ref. 3D-FD18180

Información del producto

• Nombre: (3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)methanone
• Sinónimos: Benzbromarone3,5-Dibromo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl ketone2-Ethyl-3-(3,5-dibromo-4-hydroxybenzoyl)benzofuran, (3,5-Dibromo-4-hydroxyphenyl)(2-ethylbenzofuran-3-yl)methanone, (3,5-Dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone, 2-Ethyl-3-(3,5-dibromo-4-hydroxybenzoyl)benzofuran, 3,5-Dibromo-4-Hydroxyphenyl-2-Ethylbenzo[B]Furan-3-Yl Ketone, 3,5-Dibromo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl ketone, Azubromaron, Benzbromaron, Besuric, Desuric, Ketone, 3,5-dibromo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl, L 2214, L 2214-Labaz, Max-Uric, Methanone, (3,5-dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)-, Minuric, Mj 10061, NSC 85433, Narcaricin, Normurat, Uricovac, Urinorm

Descripción

3,5-Dibromo-4-hydroxyphenyl-(2-ethyl-3-benzofuranyl)methanone (DBF) is a synthetic molecule that has been shown to be effective against obesity by reducing the size of fat cells. DBF was originally developed as an anti-inflammatory drug for psoriasis and arthritis. It has also been shown to have antioxidant and anti-cancer properties. DBF binds to toll-like receptor 4 (TLR4), which is involved in the inflammatory response, and inhibits its activation. This inhibition leads to a decrease in proinflammatory cytokines such as tumor necrosis factor alpha (TNFα). DBF also reduces the mitochondrial membrane potential, which may be due to its ability to inhibit ATP production by mitochondria and/or block mitochondrial protein synthesis.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 424.08 g/mol
• Fórmula: C₁₇H₁₂Br₂O₃
• Pureza: Min. 95%
• Color/Forma: Powder